Medprogresas, UAB revenue, profit
Credit Risk:
| Year | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Sales revenue | 116 989 € | 280 439 € | 258 020 € | 262 983 € | |
| Profit (loss) before taxes | |||||
| Profit before taxes margin | |||||
| Net profit (loss) | -8 005 € | -20 144 € | 9 402 € | 12 704 € | 766 € |
| Net profit margin | -17,22 % | 3,35 % | 4,92 % | 0,29 % | |
| Equity capital | -5 505 € | -25 649 € | 18 752 € | 31 456 € | 32 223 € |
| Amounts payable and other liabilities | 212 788 € | 339 630 € | 283 800 € | 213 596 € | 175 823 € |
| Non-current assets | 97 538 € | 258 146 € | 232 676 € | 185 016 € | 131 606 € |
| Current assets | 109 745 € | 55 835 € | 66 750 € | 56 708 € | 72 738 € |
Get the latest financial report for the year 2025 with the data company submitted to the National Register Center. 2025 m. Reports »
Only 45 Eur